Abstract:Ethnopharmacological relevance The rhizome of Curcuma wenyujin Y.H. Chen & C. Ling, also known as Wen-E-Zhu, has been used for cancer treatment since ancient times, with roots dating back to the Song Dynasty. Elemene (EE), a sesquiterpene extract with potent anticancer properties, is extracted from Wen-E-Zhu, with β-elemene (BE) being its main active compound, along with trace amounts of β-caryophyllene (BC), γ-elemene and δ-elemene isomers. EE has demonstrated broad-spectrum anti-cancer effects and is commonly used in clinical treatments for various types of malignant cancers, including lung cancer. Studies have shown that EE can arrest the cell cycle, inhibit cancer cell proliferation, and induce apoptosis and autophagy. However, the exact mechanism of its anti-lung cancer activity remains unclear and requires further research and investigation. Aim of the study In this study, the possible mechanism of EE and its main active components, BE and BC, against lung adenocarcinoma was investigated by using A549 and PC9 cell lines. Materials and methods The subcutaneous tumor model of nude mice was constructed to evaluate the efficacy of EE in vivo , then the in vitro half-inhibitory concentration (IC 50 ) of EE and its main active components, BE and BC, on A549 and PC9 cells at different concentrations were determined by CCK-8. Flow cytometry was used to detect the apoptosis and cycle of A549 and PC9 cells treated with different concentrations of BE and BC for 24 h. Non-targeted metabolomics analysis was performed on A549 cells to explore potential target pathways, which were subsequently verified through kit detection and western blot analysis. Results Injection of EE in A549 tumor-bearing mice effectively suppressed cancer growth in vivo . The IC 50 of EE and its main active components, BE and BC, was around 60 μg/mL. Flow cytometry analysis showed that BE and BC blocked the G 2 /M and S phases of lung adenocarcinoma cells and induced apoptosis, leading to a significant reduction in mitochondrial membrane potential (MMP). Results from non-targeted metabolomics analysis indicated that the glutathione metabolism pathway in A549 cells was altered after treatment with the active components. Kit detection revealed a decrease in glutathione (GSH) levels and an increase in the levels of oxidized glutathione (GSSG) and reactive oxygen (ROS). Supplementation of GSH reduced the inhibitory activity of the active components on lung cancer and also decreased the ROS content of cells. Analysis of glutathione synthesis-related proteins showed a decrease in the expression of glutaminase, cystine/glutamate reverse transporter (SLC7A11), and glutathione synthase (GS), while the expression of glutamate cysteine ligase modified subunit (GCLM) was increased. In the apoptosis-related pathway, Bax protein and cleaved caspase-9/caspase-9 ratio were up-regulated and Bcl-2 protein was down-regulated. Conclusions EE, BE, and BC showed significant inhibitory effects on the growth of lung adenocarcinoma cells, and the mechanism of action was linked to the glutathione system. By down-regulating the expression of proteins related to GSH synthesis, EE and its main active components BE and BC disrupted the cellular redox system and thereby promoted cell apoptosis.

Retracted: Beta-Elemene Against Human Lung Cancer Via Up-Regulation of P53 Protein Expression to Promote the Release of Exosome (retracted Article. See Vol. 96, Pg. 120, 2016)

RETRACTED: Β-Elemene Against Human Lung Cancer Via Up-Regulation of P53 Protein Expression to Promote the Release of Exosome

β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome

β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.

Β-Elemene Inhibits Tumor-Promoting Effect of M2 Macrophages in Lung Cancer.

Inhibitory Effect Of Beta-Elemene On Human Breast Cancer Cells

β-elemene reverses the drug resistance of A549/DDP lung cancer cells by activating intracellular redox system, decreasing mitochondrial membrane potential and P-glycoprotein expression, and inducing apoptosis.

β-elemene regulates endoplasmic reticulum stress to induce the apoptosis of NSCLC cells through PERK/IRE1α/ATF6 pathway.

Inhibitory effect of β-elemene on human breast cancer cells.

β-elemene induces glioma cell apoptosis by downregulating survivin and its interaction with hepatitis B X-interacting protein.

Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression

Antitumor effect of β-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death

β-elemene reverses chemoresistance of breast cancer via regulating MDR-related microRNA expression.

[Beta-Elemene Enhances Aclarubicin-Induced Apoptotic Effect in HL-60 Cells and Its Mechanism.].

β-elemene inhibits the proliferation of T24 bladder carcinoma cells through upregulation of the expression of Smad4.

Reversion of multidrug resistance in a chemoresistant human breast cancer cell line by β-elemene.

β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest

Anticancer effects of β-elemene in gastric cancer cells and its potential underlying proteins: a proteomic study.

Effect of β-elemene on the proliferation and apoptosis of human lung cancer A549 and H460 cells

Beta-Elemene Inhibits Non-Small Cell Lung Cancer Cell Migration And Invasion By Inactivating The Fak-Src Pathway

Elemene induces cell apoptosis via inhibiting glutathione synthesis in lung adenocarcinoma